[1] Article Title: Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature
	•	Line(s): 2–3
	•	Section: Title Page
	•	Quote(s): “Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature”

⸻

[2] Publication Year: 2025
	•	Line(s): 22
	•	Section: Title Page
	•	Quote(s): “© The Author(s) 2025”

⸻

[3] Region: Europe
	•	Line(s): 48
	•	Section: Introduction
	•	Quote(s): “to enable comparison with… a nationwide registry… in the Netherlands”

⸻

[4] Country: Netherlands
	•	Line(s): 48, 64
	•	Section: Introduction, Acknowledgements
	•	Quote(s):
	•	“comparison with… a nationwide registry… in the Netherlands”
	•	“Radboud university medical center, Nijmegen, the Netherlands”

⸻

[5] Coverage Area: National
	•	Line(s): 48
	•	Section: Introduction
	•	Quote(s): “a nationwide registry of newly diagnosed neuromuscular disorders in the Netherlands”

⸻

[6] Study Design: Systematic literature review with summary statistics and pooled estimate comparison
	•	Line(s): 40–42
	•	Section: Methods
	•	Quote(s): “Pubmed was searched… from 1990 to 2023”
“we searched for meta-analyses to compare the found mean prevalence rates…”

⸻

[7] Study Population: General population
	•	Line(s): 44
	•	Section: Methods – Inclusion criteria
	•	Quote(s): “concerning the general population, not (a) specific ethnic group(s)”

⸻

[8] Population Characteristics: NR
	•	Line(s): 36–37
	•	Section: Methods
	•	Quote(s): “contrary to the previous work it did not report age- and sex distributions”

⸻

[9] Data Source Type: Published literature
	•	Line(s): 40
	•	Section: Methods
	•	Quote(s): “Pubmed was searched… to identify peer-reviewed literature”

⸻

[10] Data Source Details: PubMed-indexed peer-reviewed articles (1990–2023)
	•	Line(s): 40–43
	•	Section: Methods
	•	Quote(s):
	•	“Pubmed was searched… to identify peer-reviewed literature from 1990 to 2023”
	•	“Full search details are provided in the Supplementary materials Table 1”

⸻

[11] Study Timeline Type: Neither prospective nor retrospective (literature-based synthesis)
	•	Line(s): 40–43
	•	Section: Methods
	•	Quote(s): “Pubmed was searched… to identify peer-reviewed literature”

⸻

[12] Number of Sites: Multiple (as a review, covers studies from many countries)
	•	Line(s): Table 2 (references studies from 25+ countries)
	•	Section: Results
	•	Quote(s): “Table 2… arranged by anatomical location and in alphabetical order, accompanied by the papers reporting on their incidence and prevalence”

⸻

[13] Study Start Year: 1990
	•	Line(s): 40
	•	Section: Methods
	•	Quote(s): “peer-reviewed literature from 1990 to 2023”

⸻

[14] Study End Year: 2023
	•	Line(s): 40
	•	Section: Methods
	•	Quote(s): “peer-reviewed literature from 1990 to 2023”

⸻

[15] Main Ethnicity: NR
	•	Line(s): 44
	•	Section: Methods – Inclusion criteria
	•	Quote(s): “concerning the general population, not (a) specific ethnic group(s)”

⸻

[16] Ethnicity Details: NR
	•	Line(s): 44
	•	Section: Methods – Inclusion criteria
	•	Quote(s): Same as above.

⸻

[17] Disease Studied: 17 neuromuscular disorders (including CMT, CIDP, IBM, etc.)
	•	Line(s): Table 1, Page 4
	•	Section: Results – Table 1
	•	Quote(s): “The 17 neuromuscular disorders included in this study… progressive (spinal) muscular atrophy, Charcot-Marie-Tooth disease…”

⸻

[18] Diagnosis Method: NR (study aggregates published estimates)
	•	Line(s): 44
	•	Section: Methods – Inclusion criteria
	•	Quote(s): “methods of ascertainment and calculation of disease frequency mentioned”

⸻

[19] Diagnosis Criteria Details: NR
	•	Line(s): 44
	•	Section: Methods – Inclusion criteria
	•	Quote(s): Same as above.

⸻

[20] Disease Phase: Chronic (selection criteria prioritized chronic disorders)
	•	Line(s): 35
	•	Section: Researched neuromuscular disorders
	•	Quote(s): “2) the disorder is chronic”

⸻

[21] Cohort Age Group: Mixed
	•	Line(s): 34–35
	•	Section: Researched neuromuscular disorders
	•	Quote(s): “1) the disorder is also diagnosed in adulthood”

⸻

[22] Female % in Cohort: NR
	•	Line(s): 36–37
	•	Section: Methods
	•	Quote(s): “did not report age- and sex distributions”

⸻

[23] Consanguinity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): Not mentioned.